OPKO Health
OPK
NZ$2.16
Share price
0.00%
Change (1 day)
6.79%
Change (1 year)
Categories
Market capitalization of OPKO Health (OPK)
Market cap: NZ$1.71 Billion
As of June 2025 OPKO Health has a market cap of NZ$1.71 Billion. This makes OPKO Health the world's 5659th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of OPKO Health from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$1.71 B | -2.85% |
| 2024 | NZ$1.76 B | -4.35% |
| 2023 | NZ$1.84 B | 21.34% |
| 2022 | NZ$1.52 B | -68.29% |
| 2021 | NZ$4.79 B | 30.81% |
| 2020 | NZ$3.66 B | 150.87% |
| 2019 | NZ$1.46 B | -44.43% |
| 2018 | NZ$2.63 B | -31.83% |
| 2017 | NZ$3.85 B | -48.44% |
| 2016 | NZ$7.48 B | -6.48% |
| 2015 | NZ$8.00 B | 45.25% |
| 2014 | NZ$5.51 B | 30.05% |
| 2013 | NZ$4.23 B | 137.16% |
| 2012 | NZ$1.78 B | -1.97% |
| 2011 | NZ$1.82 B | 49.99% |
| 2010 | NZ$1.21 B | 90.03% |
| 2009 | NZ$0.63 B | 15.25% |
| 2008 | NZ$0.55 B | -16.39% |
| 2007 | NZ$0.66 B | 3136.85% |
| 2006 | NZ$20.5 M | 102.49% |
| 2005 | NZ$10.12 M | 30.93% |
| 2004 | NZ$7.73 M | -64.4% |
| 2003 | NZ$21.71 M | 100.65% |
| 2002 | NZ$10.82 M | -91.66% |
| 2001 | NZ$0.12 B | -50.92% |
| 2000 | NZ$0.26 B | 77.52% |
| 1999 | NZ$0.14 B | 11.81% |
| 1998 | NZ$0.13 B | 27.84% |
| 1997 | NZ$0.10 B | 348.05% |
| 1996 | NZ$23.25 M |
End of Day market cap according to different sources
On Jun 20th, 2025 the market cap of OPKO Health was reported to be:
NZ$1.71 Billion
NZ$1.71 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | NZ$604.25 B | 35,128.91% | 🇺🇸 USA |
 Abbott Laboratories ABT | NZ$387.93 B | 22,517.07% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | NZ$92.26 B | 5,279.26% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | NZ$33.27 B | 1,839.75% | 🇮🇱 Israel |
 Alnylam Pharmaceuticals
ALNY | NZ$67.70 B | 3,847.18% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | NZ$159.88 B | 9,221.63% | 🇺🇸 USA |
 LabCorp LH | NZ$36.74 B | 2,042.57% | 🇺🇸 USA |
 Ardelyx ARDX | NZ$1.42 B | -16.74% | 🇺🇸 USA |